Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MedAdvisor Limited ( (AU:MDR) ) has provided an announcement.
MedAdvisor Limited announced that its securities have been suspended from quotation on the ASX due to the company’s failure to submit its FY25 Financial Report by the deadline. The company plans to lodge the audited report during the week starting 6 October 2025. This suspension could impact the company’s market perception and stakeholder confidence, highlighting the importance of timely financial reporting.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Solutions is a leader in pharmacy-driven patient engagement solutions, offering personalized experiences to simplify the medication journey. Utilizing THRiV, a cloud-based, AI-enabled platform, the company enhances pharmacy workflows and patient engagement, working with over 34,000 pharmacies across the US, reaching over two-thirds of the population.
Average Trading Volume: 939,764
Technical Sentiment Signal: Sell
Current Market Cap: A$26.56M
For an in-depth examination of MDR stock, go to TipRanks’ Overview page.